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ABSTRACT 
Purpose: The ability to obtain patient-specific organ doses for CT will open the door to new applications such as 
personalized selection of scan factors and individualized risk assessment, leading to the ultimate goal of achieving low-
dose and optimized CT imaging. One technical barrier to advancing CT dosimetry has been the lack of computational 
tools for automatic patient-specific multi-organ segmentation of CT images, coupled with rapid organ dose quantification. 
This study aims to demonstrate the feasibility of combining deep-learning algorithms for automatic segmentation of 
radiosensitive organs from CT images and GPU-based Monte Carlo rapid organ dose calculation. 
Methods: A deep convolutional neural network (CNN) based on the U-Net for organ segmentation is developed and 
trained to automatically delineate radiosensitive organs from CT images. Two databases are used: the Lung CT 
Segmentation Challenge 2017 (LCTSC) dataset that contains 60 thoracic CT scan patients each with 5 segmented 
organs, and the Pancreas-CT (PCT) dataset that contains 43 abdominal CT scan patients each with 8 segmented 
organs. A five-fold cross-validation of the new method is performed on both sets of data. Dice Similarity Coefficient 
(DSC) is used to evaluate the segmentation performance against the ground truth.  A GPU-based Monte Carlo dose 
code, ARCHER, is used to calculate patient-specific CT organ doses. The proposed method is tested in terms of Relative 
Dose Error (RDE). To demonstrate the potential improvement of the new methods, organ dose results are compared 
against those obtained for population-average phantoms used in an off-line dose reporting software, VirtualDose, at 
Massachusetts General Hospital. 
Results: For the group of 60 patients from LCTSC dataset, the median DSCs are found to be 0.97 (right lung), 0.96 
(left lung), 0.93 (heart), 0.88 (spinal cord) and 0.78 (esophagus). For the group of 43 patients from PCT dataset, the 
median DSCs are found to be 0.96 (spleen), 0.96 (liver), 0.95 (left kidney), 0.89 (stomach), 0.87 (gall bladder), 0.79 
(pancreas), 0.74 (esophagus), and 0.64 (duodenum). Comparing with the organ dose results from population-averaged 
phantoms, the new patient-specific method achieved the smaller RDE range on all organs: -4.3%~1.5% (vs -
31.5%~33.9%) for the lung, -7.0%~2.3% (vs -15.2%~125.1%) for the heart, -18.8%~40.2% (vs -10.3%~124.1%) for the 
esophagus, -5.6%~1.6% (vs -20.3%~57.4%) for the spleen, -4.5%~4.6% (vs -19.5%~61.0%) for the pancreas, -
2.3%~4.4% (vs -37.8%~75.8%) for the left kidney, -14.9%~5.4% (vs -39.9% ~14.6%) for the gallbladder, -0.9%~1.6% 
(vs -30.1%~72.5%) for the liver, and -23.0%~11.1% (vs -52.5%~-1.3%) for the stomach. The trained automatic 
segmentation tool takes less than 5 seconds in a patient for all 103 patients in the dataset.  The Monte Carlo radiation 
dose calculations performed in parallel with the segmentation using the GPU-accelerated ARCHER code takes less 
than 4 seconds in a patient to achieve <0.5% statistical uncertainty in all organ doses for all 103 patients in the database.   
Conclusion: It is feasible to perform streamlined automatic organ segmentation from patient-specific CT images and 
rapid GPU-based Monte Carlo dose quantification with clinically acceptable accuracy and efficiency.  
Keywords: CT organ dose, patient-specific, multi-organ segmentation, Monte Carlo, Convolutional neural network.  
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1. INTRODUCTION 
In the United States, the number of CT examinations increased 20 folds between the 1980s and 2010s, owing to rapid 
improvements in multi-detector CT (MDCT) technologies 1-3. In 2018, about 88.7 million CT examinations were 
performed in the United States alone, which represented a substantial increase from 21 million exams in 1995 4. The 
abdomen and chest regions represent the most frequently scanned body regions accounting for more than a third of all 
CT examinations. Given the rising use of CT and concerns over associated radiation risks, the American College of 
Radiology (ACR) has called for more research and development in patient-specific dose quantification, scanner 
optimization, and protocol comparison 1.  
The currently displayed CTDIvol and DLP are technical dose descriptors and do not represent or take into account 
patient body habitus (size or shape), attenuation, scanned anatomy, age, gender, or actually absorbed radiation doses 
5. Although CTDIvol and DLP provide a good method to compare scanners and scan protocols, they cannot be used to 
compare, monitor, or assess patient-specific radiation doses from CT.  For this reason, size-specific dose estimates 
(SSDE) have been recommended as an improved approach that takes into account for patient body habitus  6. Many 
methods of generating organ-specific dose databases have been reported  7-15. These methods require the Monte Carlo 
simulations of CT scanner components as well as radiation interactions with whole-body computational phantoms that 
contain organs/tissues explicitly defined in tiny voxels in accordance with the “Reference-Man” concept – population 
averaged anatomical parameters originally defined for radiation protection purposes 16. However, the process that was 
required to create such whole-body phantoms is prohibitively complex for routine analysis of patient-specific images.  
As a result, most clinical end-users can only perform CT organ dose assessment using “off-line” software tools, such as 
VirtualDose 15, that are based on databases pre-calculated from a library of population-averaged phantoms. In contrast, 
in radiation cancer treatment, delineation of the target volume and adjacent healthy organs at risk (OARs) is performed 
routinely using patient-specific images, followed by rapid dose calculation and inverse treatment plan optimization to 
minimize normal tissue complication probability (NTCP) 17-19. Recently, GPU-based Monte Carlo dose computing codes, 
including ARCHER 20, 21, can achieve clinically acceptable speeds for both patient CT imaging dose assessment and 
for treatment planning. Therefore, patient-specific organ dose computing methods already exist. 
A prospective patient-specific organ dose method will be a game changer in CT and can help extend the existing 
tube-current modulation techniques by taking full advantage of organ localization and distribution of organ doses. It can 
also aid imaging physicians make informed and prospective decisions regarding delivery of doses based on the clinical 
question, expected disease distribution and organ dose distribution. Such prospective decisions regarding radiation 
dose delivery from CT can help usher personalized scan protocols with truly organ dose-modulated techniques. 
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Obviously, one technical barrier is the lack of organ localization/segmentation as well as rapid organ dose prediction 
tools. 
Here we are interested in organ dose quantification for a set of radiosensitive organs in every patient undergoing 
CT scans, for radiation protection purposes (instead of cancer treatment planning purposes). Segmentation of 
radiosensitive organ volumes from CT images has long been a challenging task to the medical physics community 22. 
Manual organ segmentation is labor-intensive and user-dependent, making the approach impractical for clinical 
applications involving patient-specific images. Until recently, methods of automatic segmentation of organs relied on 
low-level image features that require strong prior knowledge about the anatomical structures and are insufficient 23. The 
advent of deep learning methods involving convolutional neural network (CNN) has brought an unprecedented level of 
innovation to the field of image segmentation 24-27. The state-of-the-art models in organ segmentation are variants of 
encoder-decoder architecture such as the Fully Convolutional Networks (FCN) 28 and U-Net 29. However, these models 
are trained usually for specific organs and cannot be easily extended to multi-organ segmentation needed for organ 
dosimetry for CT. Recently, Trullo et.al. 30 used a modified 2D FCN to segment four organs at risks from CT images and 
apply Conditional Random Fields (CRF) to further improve the segmentation performance. Gibson et al. 31 applied a 3D 
Dense V-Network to segment eight organs from CT images for navigation in endoscopic pancreatic and biliary 
procedures. However, these studies did not perform organ dose calculations for patients who receive the CT scans. 
Recent studies by other groups that did consider CT organs dose evaluations employed traditional organ segmentation 
algorithm such as feature-based or atlas-based methods 32, 33. Finally, without the necessary accuracy and efficiency, 
patient-specific dosimetry tools would not become a viable part of the clinical workflow. 
This  study 34, 35 aims to demonstrate the feasibility of a streamlined fast patient-specific CT organ dose assessment 
method that performs segmentation of multiple organs from patient-specific CT images using deep CNN algorithms and 
GPU-accelerated Monte Carlo dose calculations using the ARCHER code in a parallel computational workflow as 
illustrated in Fig. 1. This is the first study to combine these two tools to achieve the computational accuracy and efficiency 
required for routine clinical applications.  In subsequent sections, we describe steps and methods, summarize results, 
discuss limitations before drawing conclusions. 
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Fig. 1. The overall parallel computational process of the method of patient-specific organ dose assessment for 
CT using multi-organ segmentation CNN algorithms coupled with a GPU Monte Carlo dose engine, ARCHER 
 
2. MATERIALS AND METHODS 
2.A Organ segmentation  
2.A.1 Datasets and image preprocessing 
In this study, two publically available datasets were used: (1) The 2017 Lung CT Segmentation Challenge  (LCTSC) 
36-38, which contains 60 thoracic CT scan patients with 5 segmented organs (left lung, right lung, heart, spinal cord, and 
esophagus). (2) Pancreas-CT (PCT), which contains 43 abdominal contrast enhanced CT scan patients with 8 
segmented organs (the spleen, left kidney, gallbladder, esophagus, liver, stomach, pancreas and duodenum) 26, 31, 38, 39. 
For each patient in these two datasets, the Hounsfield Unit (HU) values were processed using a minimum threshold of 
-200 and a maximum threshold of 300 prior to being normalized to yield values between 0 to 1. In order to focus on 
organs and suppress the background information, we cropped and reserved the regions of interest according to the 
body contour in the original CT images and use it as training data. Finally, to circumvent the computer memory limitation, 
data downsampling was performed using linear interpolation for CT images and using nearest interpolation for the labels. 
The image resolution in the LCTSC datasets was resampled to 2 mm x 2 mm x 2.5 mm. To further improve the 
segmentation performance of the esophagus and spinal cord, the volumes of these two organs were cropped separately 
for a further step we called “fine segmentation”. The image resolution of these two organs was resampled to 1 mm x 1 
mm x 2.5 mm. In the PCT dataset, the size of CT images was resampled to 144 x 144 x 144 pixels, which was found to 
generate better segmentation performance than the original resolution. Here in the PCT dataset, the training and 
resampling served to validate the general method proposed in this study. To achieve better computational efficiency, 
small organs in the PCT database were not subjected to the resampling process used for the LCTSC database.  
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2.A.2 Network architecture 
The proposed network in this study is based on the 3D U-Net 29. As shown in Fig. 2, the network consists of an 
encoder and a decoder. The encoder extracts image features while the decoder performs a voxel-level 
classification to achieve organ segmentation. The encoder contains 4 repeated residual blocks. Each block 
consists of 4 convolutional modules and each convolutional module is composed by a convolution layer with the 
kernel of 3x3x3, an instance normalization, and a leaky rectified linear unit. For each residual block, the stride of 
convolution layer in the convolutional modules is 1x1x1 except for the last convolutional module in which the stride 
is 2x2x2 to achieve the purpose of downsampling, and there is a spatial dropout layer between the early two 
convolutional modules to prevent the network from overfitting. The decoder contains 4 repeated segmentation 
blocks. Each block consists of 2 convolutional modules and 1 deconvolutional module. Four dashed arrows in the 
figure indicate four skipping connections that copy and reuse early feature-maps as the input to later layers having 
the same feature-map size by a concatenation operation to preserve high-resolution features. In the final 3 
segmentation blocks, a 1×1×1 convolution layer is used to map the feature tensor to the probability tensor with the 
channels of the desired number of classes, n, before all results are merged by the upsampling operation to 
enhance the precision of segmentation results. Finally, a SoftMax activation is used to output a probability of each 
class for every voxel 40. 
 
FIG. 2. The network architecture.  
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2.A.3 Training 
    For the LCTSC dataset, the 60 patients are divided into 5 groups with 12 patients per group. For the PCT dataset, 
the 43 patients are divided into 5 groups with 8 or 9 patients per group. Then the 5-fold cross-validation is performed. 
At the training stage, we first randomly extracted the patches from the resampled CT images to achieve data diversity 
and to prevent overfitting. The patch size is 96x96x96 in LCTSC and 128x128x128 in PCT. As noted earlier, the patch 
size for the fine segmentation of the esophagus and spinal cord in LCTSC is 32x32x32. Then, the network is trained by 
the patch and its corresponding labels. The loss function is defined as the weighted dice similarity coefficient as: 
Loss = −
1
𝑁∗𝐾
 ∑ ∑
2∗∑ (𝑝𝑖,𝑘,𝑣∗ 𝑦𝑖.𝑘.𝑣)+𝜀
𝑉
𝑣=1
∑ 𝑝𝑖,𝑘,𝑣+ ∑ 𝑦𝑖,𝑘,𝑣
𝑉
𝑣=1
𝑉
𝑣=1 +𝜀
  𝐾𝑘=1
𝑁
𝑖=1 , 
where 𝑝𝑖,𝑘,𝑣 is the predicted probability of the voxel 𝑣 of the sample 𝑖 belonging to the class 𝑘, 𝑦𝑖,𝑘,𝑣 is the ground truth 
label (0 or 1), N is the number of samples, K is the number of classes, V is the number of voxels in one sample, and 𝜀 
is a smooth factor (set to be 1 in this study). The initial learning rate is 0.0005, and the Adam algorithm 41 is used to 
update the parameters of the network. The validation loss is calculated for every epoch, and the learning rate is halved 
when the validation loss no longer decreases after 30 consecutive epochs. The training process is terminated when the 
validation loss stops to decrease after 50 consecutive epochs. 
    
2.A.4 Testing 
In the testing stage, we first extract the patches from each CT images with a moving window with the size of 
96x96x96 in LCTSC and 128x128x128 in PCT. The stride is 24 in LCTSC and 16 in PCT. In other words, we extract 
multiple patches from one patient and feed them into the network. The output of the network is a probability tensor for 
each patch. Then we merge all probability tensors from the same patient with a mean operator in the overlapping area 
to obtain the final probability tensor. Next, the class of each voxel is determined by the largest probability, which is the 
preliminary results of organ segmentation and the value of each voxel is the class number. Last, using the nearest 
neighbor interpolation, we resample the preliminary segmentation results to the size of original CT images to obtain the 
final organ segmentation results. It is worth noting that, for the fine segmentation of very small organs of esophagus and 
spinal cord in LCTSC, we first crop their own volume according to the multi-organ segmentation results, and then the 
volume is resampled to 1mm x 1mm x 2.5mm. Next, similar to the previous multi-organ segmentation, we extract the 
patches of 32x32x32 with a moving stride of 8x8x8 and separately feed them into their own networks. Finally, the fine 
segmentation of the esophagus and spinal cord were filled into the initial multi-organ segmentation results. 
All experiments described above were performed on a Linux computer system. Keras with TensorFlow as the 
backend was used as the platform for designing and training the neural network 42. The hardware includes: (1) GPU -  
Nvidia GeForce Titan X Graphics Card with 12GB memories, and (2) CPU - Intel Xeon Processor X5650 with 16GB 
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memories. 
 
2.B Organ dose calculations 
A GPU-accelerated Monte Carlo code, ARCHER, previously developed by members of this group was used in this 
study to calculate organ doses 20, 21, 43. ARCHER is used in this study to simulate the transport of low-energy X-ray 
photons in heterogeneous media defined by the patient CT images where photoelectric effect, Compton scattering, and 
Rayleigh scattering can take place. CT scan protocols are predefined for ARCHER, including a combination of scan 
mode (helical or axial), beam collimation (5, 10, or 20 mm) and kVp (80, 100, 120 or 140). Fig. 3 illustrates the simulation 
environment involving a patient and a CT scanner. 
 
FIG. 3. CT dose simulation model of a patient undergoing a CT scan. 
 
This study considered a scanner model representing a GE Lightspeed Pro 16 multi-detector CT that has been 
validated in our previous studies 44, 45, although a newer scanner model can be similarly created when needed in the 
future. The scanning protocol considered in this study includes 120 kVp, 20 mm beam collimation, axial body scan at a 
constant 100 mAs. CT scanner’s continuous rotational motion is simulated using the step-and-shoot pattern, with each 
rotation approximated by 16 discrete positions 44. Combining the newly segmented organ masks and voxel-wise 
dose maps calculated by ARCHER for a specific patient as is done in radiation treatment planning, we can derive 
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the average absorbed dose for each organ of interest, as illustrated earlier in Fig 1. The computational speed is 
evaluated to make sure it is acceptable as part of the clinical workflow. 
To show the potential clinical impact of the new method, patient-specific organ dose results are compared against 
organ doses derived from population-average phantoms used in the VirtualDose software 45, 46. Fig.4 shows the RPI-
Adult Male (73 kg in weight and 176 cm in height) and RPI-Adult Female (60 kg in weight and 163 cm in height) phantoms 
that were designed in accordance with anatomical parameters for the 50th percentile of the population 46. When the 
weight and height of an adult patient are unspecified, the clinical organ dose assessment procedure at Massachusetts 
General Hospital usually picks these standard adult phantoms from the VirtualDose software to represent that patient.  
 
FIG. 4. RPI-Adult Male (left) and RPI-Adult Female (right) phantoms in the VirtualDose software that were designed in 
accordance with anatomical parameters for the 50th percentile of the population, thus bringing errors when compared 
with patient-specific organ doses 46 
 
2.C Segmentation and organ dose evaluation criteria 
The Dice Similarity Coefficient (DSC) was used to evaluate the performance of organ segmentation 47:  
𝐷𝑆𝐶 =   
2|𝐴 ∩  𝐵|
|𝐴|  +  |𝐵|
 
where A is the volume of manually segmented organ (i.e., the ground truth) and B is the volume of the organ segmented 
by the network. The DSC ranges from 0 to 1 with the latter indicating a perfect performance. The Relative Dose Error 
(RDE) was used to evaluate the accuracy of dose calculation for each organ: 
𝑅𝐷𝐸 =  
𝐷 − 𝐷𝑟
𝐷𝑟
∗ 100% 
where D is the organ dose calculated by ARCHER using patient-specific phantom consisting of either automatically 
segmented organs using the proposed the network (i.e., our method) or organs in the population-average phantom, and 
Dr is the reference organ dose calculated by ARCHER using patient-specific phantom and manually segmented organ. 
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3．Results 
3.A Organs segmentation 
 The performance of our network in organ segmentation is evaluated in terms of the DSC. As shown in Fig. 5, the 
segmentation results of all organs are summarized in these two box plots. For 60 patients from LCTSC, we achieved 
median DSCs of 0.97 (right lung), 0.96 (left lung), 0.93 (heart), 0.88 (spinal cord), and 0.78 (esophagus) as can be seen 
in Fig. 5 (a).  For 43 patients from PCT, we achieved median DSCs of 0.96 (spleen), 0.96 (liver), 0.95 (left kidney), 0.89 
(stomach), 0.87 (gall bladder), 0.79 (pancreas), 0.74 (esophagus), and 0.64 (duodenum) as can be seen in Fig. 5 (b). 
These values are very good and, as discussed later, meet the needs for CT organ dose reporting.  Fig. 6 (a) and (b) 
show visual comparison of manual and automatic multi-organ segmentation results from both LCTSC and PCT, 
respectively, in axial, sagittal, coronal, and 3D views. 
 
 
FIG. 5. Evaluation of organ segmentation performance in terms of DSC. (a) Data based on 60 patients from the LCTSC 
database. (b) Data based on 43 patients from the PCT database. 
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FIG. 6. Examples for visual comparison of organ segmentation between manual methods from LCTSC or PCT database 
(showed in the upper row in each panel) and our automatic method (showed in the upper row in each panel), in terms 
of axial, sagittal, coronal, and 3D views (from left to right). (a) LCTSC database showing left lung (yellow), right lung 
(cyan), heart (blue), spinal cord (green), and esophagus (red). (b) PCT database showing spleen (green), pancreas 
(white), left kidney (yellow), gallbladder (blue), esophagus (red), liver (bisque), stomach (magenta), and duodenum 
(purple). 
 
The LCTSC database includes Reference DSC results provided by the organizer of the on-line challenge and DSC 
results submitted by 7 participating contestants who analyzed 12 patient CT datasets 37. Table 1 summarizes the 
comparison of DCS results from this study with those from the LCTSC. The data show that our method has achieved 
comparable performance levels with those from the LCTSC database for the left lung, right lung, heart, and spinal cord.  
For the esophagus, which yielded worst performance among these five organs in the LCTSC database, our method 
scored better than all the 7 contestants, but ranks behind the Reference DSC result.  These results suggest that our 
automatic organ segmentation method, which is used for purposes of CT organ dosimetry, has achieved the similar 
level of accuracy for the testing cases considered in this LCTSC database.  Since the PCT database does not contain 
similar DSC data, Table 7 does not include organs in the abdominal region. 
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TABLE 1．Comparison of DSC results from this study with the Reference data and results from 7 contestants (DSC is 
given in “mean ± standard deviation”). 
 
Methods Left lung Right lung Heart Esophagus Spinal cord 
LCTSC Reference 0.96±0.02 0.96±0.02 0.93±0.02 0.82±0.04 0.86±0.04 
Method 1 0.97±0.02 0.97±0.02 0.93±0.02 0.72±0.10 0.88±0.04 
Method 2 0.98±0.01 0.97±0.02 0.92±0.02 0.64±0.20 0.89±0.04 
Method 3 0.98±0.02 0.97±0.02 0.91±0.02 0.71±0.12 0.87±0.11 
Method 4 0.97±0.01 0.97±0.02 0.90±0.03 0.64±0.11 0.88±0.05 
Method 5 0.96±0.03 0.95±0.05 0.92±0.02 0.61±0.11 0.85±0.04 
Method 6 0.96±0.01 0.96±0.02 0.90±0.02 0.58±0.11 0.87±0.02 
Method 7 0.95±0.03 0.96±0.02 0.85±0.04 0.55±0.20 0.83±0.08 
Our method 0.96±0.01 0.96±0.02 0.93±0.02 0.75±0.10 0.88±0.04 
 
3.B Organ dose calculations 
The accuracy of organ dose calculations is evaluated in terms of RDE for the purposes of CT organ dosimetry where 
10% is considered generally to be excellent. In the dataset from LCTSC, we calculated the organs doses of 60 patients 
in total, including the lung, heart, and esophagus. The left lung and right lung are treated as one organ, and the RDE of 
the spinal cord was not considered because it is not segmented in the population-average phantom. In the dataset from 
PCT, we calculated the organs doses of 43 patients in total, including the spleen, left kidney, gallbladder, liver, stomach, 
and pancreas. The duodenum is not segmented in the population-average phantom, and the esophagus in the specific 
patient is incomplete in the abdominal CT scanning, so the RDEs were not considered for the duodenum and 
esophagus. Results show that, comparing with the population-average-phantom based method (in parentheses next), 
our patient-specific method achieved the smaller RDE range for all organs: -4.3%~1.5% (vs -31.5%~33.9%) for the lung, 
-7.0%~2.3% (vs -15.2%~125.1%) for the heart, -18.8%~40.2% (vs -10.3%~124.1%) for the esophagus, -5.6%~1.6% 
(vs -20.3%~57.4%) for the spleen, -4.5%~4.6% (vs -19.5%~61.0%) for the pancreas, -2.3%~4.4% (vs -37.8%~75.8%) 
for the left kidney, -14.9%~5.4% (vs -39.9% ~14.6%) for the gallbladder, -0.9%~1.6% (vs -30.1%~72.5%) for the liver, 
and -23.0%~11.1% (vs -52.5%~-1.3%) for the stomach. These data are further compared in Fig. 7 (a) and (b) using box 
plots of RDEs for each organ in these two datasets. The ground-truth reference organ doses were calculated for the 
specific patient using ground-truth segmentation data from the original database. “Proposed method” represents the 
RDE between organ doses from our automatic segmentation and the reference organ doses, and “phantom-based 
method” represents the RDE between organ doses from the population-average phantom and reference organ doses. 
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As can been seen from data summarized earlier and the Fig. 7, the RDE values for our proposed patient-specific method 
has much smaller. In a CT scan, the height, weight, and organ topology of a patient can influence organ dose values. 
There is no doubt that it introduces some errors using population-average phantoms to replace a specific patient for 
organ dose calculation. In the case of dose to the heart, the current method of using population-average phantom in the 
VirtualDose software is found to suffer from the error range (-15.2% ~ 125.1%) due to the anatomical differences 
between the phantom and a real patient. As expected, the patient-specific method has a much smaller error range (-
7.0% ~ 2.3%) for the heart, due to difference in organ segmentation between the CNN-based method and the ground 
truth. These results suggest that the patient-specific method can bring significant (in the case of dose to the heart, 125/7 
times) improvement to the current CT organ dose assessment method that is based on population-average phantoms.  
 
FIG. 7. The box plots of RDE showing that the proposed patient-specific method has much reduced errors when 
compared against the ground truth data. (a) For 60 patients from LCTSC and (b) For 43 patients from PCT.  
 
3.C. Computational Efficiency  
The computing time in our method, includes two processes performed in parallel as illustrated previously in Figure 
1. The time for automatic organ segmentation for each patient is less than 5 seconds for all the 103 patient cases 
considered in the study.  The time to calculate a total of 1x108 photons using ARCHER code running on an Nvidia Titan 
RTX GPU card with 24 GB memory is less than 4 seconds for all 103 patients with an organ dose statistical uncertainty 
of less than 0.5%.  From our experiences, such computational accuracy and efficiency are expected to be acceptable 
as part of the routine clinical workflow. 
 
3. DISCUSSION 
 
In this study, we designed and trained a 3D CNN model to automatically segment thoracic and abdominal organs 
in patient-specific CT images using two publically available databases. In particular, we developed a fine segmentation 
procedure to treat narrow and long organs such as the esophagus and spinal cord in the LCTSC database and improved 
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their segmentation performance. In the duodenum, like the other on-line test participants, the segmentation performance 
of our network was relatively poor, because the organ and its surrounding tissues have similar pixel values in CT image 
making the boundary difficult to detect by the CNN model. Nevertheless, results from this study have clearly 
demonstrated the accuracy and efficiency of the CNN model in performing the automatic multi-organ segmentation task 
for the purposes of assessing patient organ doses.  Implementation of the proposed method can lead to significant 
improvement in the accuracy of organ dose calculation based on the population-average phantoms. 
It is important to note that the significance of this study is not about the ability to perform CNN-based automatic 
multi-organ segmentation.  As evidenced by the 2017 AAPM Thoracic Auto-Segmentation Challenge, start-of-the-art 
automatic segmentation methods, DL-based or atlas-based, can already achieve impressive performances 37.  
Therefore, the objective of this study was never to invent a new and better organs segmentation method. Instead, the 
significance of this study is that, for the first time, we have demonstrated that it is feasible to combine DL-based 
automatic multi-organ segmentation tool with the GPU-based rapid Monte Carlo dose calculation code in a streamlined 
process that takes less than 5 seconds for each patient.  With this newly demonstrated capability of “patient-specific” 
organ dose assessment, future CT scanners can take advantage of patient- and scan-specific features in a new 
paradigm – the “prospective” design of tube voltage and current modulation, beam collimation and filtering, and gantry 
angle –  leading to the ultimate goal of achieving low-dose and optimized CT imaging. 
There are several limitations in the current study. The variable and somewhat less accurate performance of our 
approach for segmenting narrow and long structures with poor soft-tissue contrast such as the esophagus and 
duodenum may be related to the relatively small size of training data in the databases causing irregularities in CT 
attenuation and position of these structures. Another limitation was that we did not assess the effect of major 
abnormalities on the organ segmentation – an issue already recognized by organizers of the 2017 Lung CT 
Segmentation Challenge 37. Likewise, diffuse abnormalities and paucity of intra-abdominal fat can have a negative effect 
on the ability of our segmentation algorithm. Further studies should consider larger patient data size and cover children 
and additional radiosensitive organs in the head and neck regions. One set of unique data already available from MGH 
is the annotated cadaver CT images that can be ideally for testing of DL-based image analysis and dosimetry algorithms 
48-50.  
Finally, it is worth noting that, with the patient-specific organ dose information, one can derive the so-called “effective 
dose” – a quantity that the American Association of Physicists in Medicine (AAPM) believes to bear significant 
uncertainty and therefore should be used only for prospective radiologic protection purposes and to help patients 
understand medical radiation dose in perspective 51. 
 
5. CONCLUSION  
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In this study, an automatic multi-organ segmentation method was developed using a CNN model that was trained 
with two publically available CT databases involving a total of 103 patients. The method takes less than 5 seconds to 
perform automatic multi-organ segmentation for a patient and, for purposes of CT organ dosimetry, has achieved the 
similar level of segmentation accuracy for the testing cases considered this study.  The organ dose calculation method 
takes less than 4 seconds for a total of 1x108 photons using the GPU-based rapid Monte Carlo code, ARCHER, to 
achieve the organ dose statistical uncertainty of better than 0.5%. These results demonstrate, for the first time, the 
excellent accuracy and efficiency of a streamlined patient-specific organ dosimetry computational tool.  Implementation 
of such methods as part of the clinical workflow can yield considerable improvement over the current CT organ dose 
methods that are based on population-average phantoms, thus opening the door to prospective patient-specific 
optimization features in the future. 
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